Is AcelRx Pharmaceuticals (ACRX) A Good Stock To Buy Now?
In this article we are going to use hedge fund sentiment as a tool and determine whether AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) is a good investment right now.
Acelrx Pharmaceuticals Inc (ACRX)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Rock Springs Capital Management Kris Jenner, Gordon Bussard, Graham Mcphail | 6,329,202 | $1,807 | +1% | 0.04% |
| 2. | D E Shaw D. E. Shaw | 3,808,993 | $1,088 | +3% | 0% |
| 3. | Engineers Gate Manager Greg Eisner | 130,716 | $37 | -18% | 0% |
| 4. | Citadel Investment Group Ken Griffin | 92,459 | $27 | -63% | 0% |
| 5. | Millennium Management Israel Englander | 85,210 | $24 | -75% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.29 | 100,000 | Director | 178,750 | 2020-06-15 | Filing | |
| $1.29 | 100,000 | Director | 178,750 | 2020-06-15 | Filing | |
| $1.33 | 7,547 | Officer, Director | 468,757 | 2020-06-15 | Filing | |
| $1.78 | 25,000 | Director | 243,750 | 2019-11-12 | Filing | |
| $1.79 | 8,379 | Officer, Director | 275,944 | 2019-11-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.00 | 5,216 | Officer | 29,795 | 2018-10-15 | Filing | |
| $5.00 | 28,351 | Officer | 54,061 | 2018-10-15 | Filing | |
| $4.50 | 6,953 | Officer | 35,011 | 2018-09-24 | Filing | |
| $5.29 | 10,161 | Officer | 41,964 | 2017-10-02 | Filing | |
| $0.00 | 13,827 | Officer | 68,504 | 2017-09-25 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 11,206 | $3,199 | 0% | |
| 2. | 3,468,944 | $990 | 0% | |
| 3. | 2,774 | $792 | 0% | |
| 4. | 2,218,010 | $633 | 0% | |
| 5. | 1,068,118 | $304 | 0% |
News See All
Hedge Funds Have Never Been Less Bullish On AcelRx Pharmaceuticals Inc (ACRX)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Is AcelRx Pharmaceuticals Inc (ACRX) A Good Stock To Buy?
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the second ...
Hedge Funds Have Never Been More Bullish On AcelRx Pharmaceuticals Inc (ACRX)
Hedge funds and other investment firms run by legendary investors like Israel Englander, Jeffrey Talpins and Ray Dalio are entrusted to manage billions of dollars of accredited investors' money because...
Hedge Funds Are Crazy About AcelRx Pharmaceuticals Inc (ACRX)
Amid an overall market correction, many stocks that smart money investors were collectively bullish on tanked during the fourth quarter.
Does AcelRx Pharmaceuticals Inc (ACRX) Stack Up Against Its Peers?
The 700+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions as of September 30.
McDonald’s Corporation (MCD), AcelRx Pharmaceuticals Inc. (ACRX) & More: Here’s Why These Stocks Are Trending Today
The US stock market is trading higher today as investors remain on the sidelines ahead of the Federal Reserve’s monetary policy meeting next week.
Should You Avoid AcelRx Pharmaceuticals Inc (ACRX)?
Is AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research.
Why Is Joseph Edelman’s Hedge Fund So Bullish On AcelRx?
In a disclosure of its holdings, Joseph Edelman's Perceptive Advisors made public that it currently owns 6.57 million shares of AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) last week.
Joseph Edelman, Perceptive Advisors Continue Bullish Streak in AcelRX Pharmaceuticals
Joseph Edelman's fund Perceptive Advisors continues its bullish streak on AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) disclosing increasing its position to over 6.57 million shares, after reporting buying...
Billionaire Hedge Funds
